|
|
|
ALDA Pharmaceuticals Corp (VEN APH) Added Apr 11, 2010
ALDA Pharmaceuticals Corp. has developed a novel infection control technology, T36®. which was originally developed for use as a hard surface disinfectant. T36® kills viruses, fungi and bacteria, including resistance strains, such as MRSA, in as little as 15 seconds. The first product for human use, T36® Antiseptic Hand Sanitizer has been approved by Health Canada. This product has distinct advantages over typical alcohol hand sanitizers in that it kills a wider range of infectious organisms, and lasts for hours on the skin to provide continued protection.
Recent News: ALDA Pharmaceuticals Amends Private Placement
ALDA Pharmaceuticals Increases Private Placement
ALDA Pharmaceuticals Appoints Medical Director
ALDA Pharmaceuticals Undertakes Private Placement
ALDA
receives FDA permission to sell products in the US
LETTER TO THE SHAREHOLDERS OF ALDA PHARMACEUTICALS CORP
Recognia….Apr 07, 2010 Bullish Continuation Wedge Target $0.49 - $0.55 range (Missed Target) APH Price day before:$0.165 Finish day posting $0.355 Current:$0.12 ------Mar 16, 2010----- Head & Shoulders Top Target $0.01 - $0.05 range (Missed Target) APH Price day before:$0.205 Finish day posting $0.195 Current:$0.12 ------Mar 05, 2010----- Head & Shoulders Top Target $0.07 - $0.11 range (Missed Target) APH Price day before:$0.24 Finish day posting $0.245 Current:$0.12
ALDA Pharmaceuticals Corp Short Positions VEN Date Outstanding Price Range July 01 to 15, 2010 $0.135 to $0.12 June 16 to 30, 2010 0 $0.145 to $0.12 June 01 to 15, 2010 0 $0.16 to $0.13 May 16 to 31, 2010 8,500 $0.19 to $0.135 May 01 to 15, 2010 1,500 $0.22 to $0.185 Apr 16 to 30, 2010 0 $0.24 to $0.195 Apr 01 to 15, 2010 3500 $0.38 to $0.165 Mar 16 to 31, 2010 0 $0.205 to $0.155 Mar 01 to 15, 2010 0 $0.26 to $0.18 Feb 16 to 28, 2010 0 $0.32 to $0.22 Feb 01 to 15, 2010 0 $0.33 to $0.265 |